Bond.az White LogoBond.az Black Logo

KeyBanc Maintains Alphabet Rating on AI Growth

KeyBanc maintains Overweight rating on Alphabet stock with $425 target, citing AI growth and product transformation. PEG ratio of 0.63 indicates reasonable valuation.

Luna Torres
ByLuna Torres- Senior Editor
|
0

Bond.az - KeyBanc has reiterated an Overweight rating and $425 price target on Alphabet stock (NASDAQ:GOOGL), citing the company's artificial intelligence transformation across its product portfolio. The target implies a P/E ratio of 29.2x for 2027, slightly below the current multiple of 29.72x, though the PEG ratio of 0.63 suggests growth at a reasonable price.

The firm noted that Alphabet is now processing more than 3.2 quadrillion tokens per month, representing a sevenfold increase year-over-year. The company scaled AI Mode from zero to more than 1 billion monthly active users within one year.

KeyBanc analyst Justin Patterson stated: "AI Is Transforming Google's Product Families; Google I/O 2026 reinforced the sheer scale at which AI can transform a large organization like Google; the Company is now processing >3.2 quadrillion (Q) tokens per month (an increase of 7x y/y) and scaled AI Mode from zero to >1B MAUs in the span of one year."

The analyst added: "As more users become accustomed to AI, Google appears to be iterating faster on Search advancements, which we believe reinforces there is an upward bias to medium-term Search revenue. Coupled with GCP, we continue to view Alphabet as having multiple levers to monetize AI."

The $425 price target represents a 29.2 times multiple on the firm's 2027 earnings estimate.

In other recent news, Alphabet has been in the spotlight with significant developments. At its annual Google I/O conference, the company highlighted advances in artificial intelligence, emphasizing expansion of the search market. Citizens maintained its Market Outperform rating on Alphabet with a price target of $515. Morgan Stanley reiterated its Overweight rating with a $375 price target. BofA Securities expressed confidence in Alphabet's AI trajectory, maintaining a Buy rating and a $430 price target.

Additionally, Alphabet's collaboration with Volvo will integrate Google Gemini AI technology into Volvo's EX60 model. OpenAI announced it will use Google's SynthID watermarking technology to identify AI-generated images.

More News
Today / 11:53
|
435

Stifel Maintains Manhattan Associates Price Target

Stifel maintains Buy rating and $200 target for Manhattan Associates. The company is investing in cloud migration and agentic AI capabilities.

0
Today / 11:52
|
256

Rosenblatt Raises 8x8 Target to $3.00

Rosenblatt raises 8x8 stock target to $3.00 after strong Q4 results. Revenue beat guidance.

0
Today / 11:52
|
385

Piper Sandler Reiterates Alphabet Overweight on AI

Piper Sandler reiterates Alphabet Overweight rating and $425 target after Google I/O AI product launches.

0
Today / 11:51
|
464

Rosenblatt Cuts Canaan Target Price to $1.30

Rosenblatt cuts Canaan stock price target to $1.30 from $2.25, maintains Buy rating. Canaan faces revenue miss in Q1 FY2026.

0
Today / 11:50
|
872

Bernstein raises Dell target to $280 on AI

Bernstein raises Dell price target to $280, citing agentic AI demand and SMCI share losses.

0
Today / 11:43
|
228

Alpha Tau Stock Gets Buy Rating, $15 Target

H.C. Wainwright reiterates Buy on Alpha Tau stock with $15 target. Company completes ReSTART trial enrollment.

0
Today / 11:42
|
472

H.C. Wainwright Reiterates Protara Buy Rating

H.C. Wainwright reiterates Buy rating on Protara Therapeutics (TARA) with $27 target. Encouraging results from lymphatic malformation and bladder cancer trials.

0
Today / 11:41
|
612

H.C. Wainwright reiterates MindWalk stock rating on platform validation

H.C. Wainwright reiterates Buy rating and $5 target on MindWalk stock, citing platform validation and strong pipeline. Read more.

0
Today / 11:40
|
376

Traws Pharma Gets $8 Price Target from H.C. Wainwright

H.C. Wainwright reaffirms Buy on Traws Pharma with $8 target. Financing secured for influenza drug trial. Read more on Bond.az.

0
Today / 11:33
|
664

Morgan Stanley raises ZTO target to $30.10

Morgan Stanley raises ZTO Express price target to $30.10 from $28.50, maintains Overweight rating, citing profit growth outlook.

0
Today / 11:33
|
701

Guggenheim reiterates Buy rating on Okta stock

Guggenheim reiterates Buy rating on Okta stock with $138 price target. Analysts expect Q1 earnings to beat consensus.

0
Today / 11:32
|
805

BTIG Lowers ServiceTitan Target, Keeps Buy

BTIG lowered ServiceTitan price target to $90 from $105, maintains Buy rating. Revenue growth 24.5%, gross margins 70%.

0
...
KeyBanc Maintains Alphabet Rating on AI Growth | Bond.az